Skip to main content

STK-06: Discharged on Statin Medication

CBE ID
0439
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

This measure captures the proportion of ischemic stroke patients who are prescribed a statin medication at hospital discharge.

This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter, STK-4: Thrombolytic Therapy, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs.

        • 1.14 Numerator

          Ischemic stroke patients prescribed statin medication at hospital discharge

        • 1.15 Denominator

          Ischemic stroke patients

        • Exclusions

          • Less than 18 years of age
          • Length of Stay > 120 days
          • Comfort measures only documented
          • Enrolled in clinical trials related to stroke
          • Admitted for elective carotid intervention
          • Discharged to another hospital
          • Left against medical advice
          • Expired
          • Discharged to home for hospice care
          • Discharged to a health care facility for hospice care
          • Documented reason for not prescribing statin medication at discharge

        • 1.13a Data dictionary not attached
          No
        • Most Recent Endorsement Activity
          Endorsed with Reserve Status Neurology Project 2015-2016
          Initial Endorsement
          Last Updated
        • Steward
          The Joint Commission
          Steward Organization POC Email
          Steward Organization Copyright

          No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.

              • Risk adjustment approach
                Off
                Risk adjustment approach
                Off
                Conceptual model for risk adjustment
                Off
                Conceptual model for risk adjustment
                Off